Typicality: | 0.432 |
Saliency: | 0.427 |
in patients with diabetes mellitus | 9 | other |
ace inhibitor → be recommended as → first-line therapy | 4 |
ace inhibitor → be → appropriate first-line therapies | 4 |
ace inhibitor → be considered → first-line therapy | 3 |
negative | neutral | positive |
0.072 | 0.710 | 0.217 |
Raw frequency | 11 |
Normalized frequency | 0.427 |
Modifier score | 0.500 |
Perplexity | 22.124 |